Published: 22 September 2016

Summary of Recommendations from the 103rd meeting of the Medicines Assessment Advisory Committee held in Wellington, on Thursday 4 August 2016 at 9:30 a.m.


Applications for consent to distribute a new medicine under section 20 / 23 / 24 of the Medicines Act 1981 (referred by the Minister of Health under section 22(2))


Oncentin, 125 mg/5mL and 250 mg/5mL, powder for oral suspension (TT50-9615, a) Actavis New Zealand Limited

No recommendation was made as this application was withdrawn prior to the meeting.


General Business


Updating the Medicines Assessment Advisory Committee Handbook to include a Deputy Chair

That Dr P Tomlinson should be appointed Deputy Chair.